Numerous studies have demonstrated the hyperactivation of key protein molecules within the PI3K/Akt/mTOR pathway across various malignant tumors, including hepatocellular carcinoma, breast cancer, and glioblastoma (Stjernström et al., 2014; Wang et al., 2014). The gene discussed is MTOR; the disease is cancer.